Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Viking Therapeutics, Inc. (VKTX) had Free Cash Flow per Share of $-0.89 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-65.56M |
|
-- |
|
-- |
|
$74.57M |
|
$-74.57M |
|
$9.01M |
|
$-65.56M |
|
$-65.56M |
|
$-65.56M |
|
$-65.56M |
|
$-65.56M |
|
$-65.56M |
|
$-74.57M |
|
$-76.83M |
|
112.13M |
|
112.13M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$827.02M |
|
-- |
|
$0.83M |
|
$827.85M |
|
$31.98M |
|
-- |
|
$0.41M |
|
$32.39M |
|
$795.46M |
|
$795.46M |
|
$795.46M |
|
112.33M |
|
| Cash Flow Statement Financials | |
$-99.39M |
|
$105.75M |
|
$0.86M |
|
$26.68M |
|
$33.88M |
|
$7.20M |
|
$24.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-99.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.24% |
|
-8.24% |
|
-7.92% |
|
-8.24% |
|
$7.08 |
|
|
Free Cash Flow per Share |
$-0.89 |
$-0.89 |
|